KY-05009 T11793
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KY-05009 pharmacologically inhibits TGF-_1-induced epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cells. KY-05009 inhibits the protein expression of TNIK and transcriptional activity of Wnt target genes and induces apoptosis in ca
CAS nr:
1228280-29-2
Purity:
98%
Molecular Weight:
352,41
SMILES:
O=C(C1=C(NC(C2=CC=C(C)C=C2)=O)SC(NC3=CC=CC=C3)=N1)N
Formula:
C18H16N4O2S
Pathway:
Stem Cells,Cytoskeletal Signaling
Target:
Wnt/beta-catenin,Wnt/beta-catenin
